ArticleNeuropsychopharmacology reports2022

Identification of factors associated with the efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder.

Tsutomu Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.